EVM
AGN

Eaton Vance Management’s Allergan Inc AGN Stock Holding History

Eaton Vance Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-323,450
Closed -$68.8M – 970
2014
Q4 		$68.8M Sell
323,450
-55,365
-15% -$11M 0.2% 118
2014
Q3 		$67.5M Sell
378,815
-92,058
-20% -$15.3M 0.2% 123
2014
Q2 		$79.7M Buy
470,873
+28,503
+6% +$4.44M 0.24% 115
2014
Q1 		$54.9M Buy
442,370
+69,732
+19% +$8.49M 0.16% 138
2013
Q4 		$41.4M Sell
372,638
-17,042
-4% -$1.63M 0.12% 155
2013
Q3 		$35.2M Sell
389,680
-15,524
-4% -$1.39M 0.11% 147
2013
Q2 		$34.1M Buy
+405,204
New +$42M 0.1% 150

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Eaton Vance Management's AGN Position: Q1 2015 in Review

Eaton Vance Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 323,450 shares — an estimated $68.8M sold.

Eaton Vance Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $79.7M in Q2 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Eaton Vance Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Eaton Vance Management sold 323,450 Allergan Inc shares in Q1 2015, an estimated $68.8M.
  • Eaton Vance Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Eaton Vance Management's Allergan Inc position peaked at $79.7M in Q2 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Eaton Vance Management's 13F filing for Q1 2015, filed 11 May 2015.